Cargando…

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid

Detalles Bibliográficos
Autor principal:	Rüther, Alric
Formato:	Texto
Lenguaje:	English
Publicado:	German Medical Science 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011317/ https://www.ncbi.nlm.nih.gov/pubmed/21289922

Ejemplares similares

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
por: Makady, Amr, et al.
Publicado: (2017)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
por: Lach, Krzysztof, et al.
Publicado: (2017)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
por: Tafuri, Giovanni, et al.
Publicado: (2016)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

Ethical analysis in HTA of complex health interventions
por: Lysdahl, Kristin Bakke, et al.
Publicado: (2016)

HTA assessment of COVID-19 interventions in Ireland
Publicado: (2020)

Why and how can HTA support evidence-informed health policymaking?
por: Gutiérrez-Ibarluzea, I, et al.
Publicado: (2022)

Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit
por: Halmesmäki, Esa, et al.
Publicado: (2016)

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA)
por: Brettschneider, Christian, et al.
Publicado: (2011)

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view
por: Giuliani, Giovanni, et al.
Publicado: (2018)

Why not integrate ethics in HTA: identification and assessment of the reasons
por: Hofmann, Bjørn
Publicado: (2014)

Patient advocate perspectives on involvement in HTA: an international snapshot
por: Scott, Anna Mae, et al.
Publicado: (2017)

HB-HTA as an implementation problem in Polish health policy
por: Gałązka-Sobotka, Małgorzata, et al.
Publicado: (2021)

Living HTA: Automating Health Economic Evaluation with R
por: Smith, Robert A., et al.
Publicado: (2022)

Bibliometrics of NIHR HTA monographs and their related journal articles
por: Royle, Pamela, et al.
Publicado: (2015)

Time to publication for NIHR HTA programme-funded studies
por: Chinnery, Fay, et al.
Publicado: (2013)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Worldwide HTA access to ICER's cost-effectiveness models
Publicado: (2020)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree
por: Dintsios, C. M., et al.
Publicado: (2019)

The impact of HTA reports on health policy: a systematic review
por: Gerhardus, Ansgar, et al.
Publicado: (2005)

HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
por: Garagiola, Elisabetta, et al.
Publicado: (2020)

POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022)

HTA56 COVID-19 from the Perspective of Intellectual Property
por: Pereira da Veiga, CR, et al.
Publicado: (2022)

International HTA Experience with Targeted Therapy Approvals for Lung Cancer
por: Maraiki, Fatma, et al.
Publicado: (2018)

Health technology assessment (HTA) increasingly important in spine research
por: van Tulder, Maurits
Publicado: (2011)

Role of NIHR HTA clinical trials on subsequent systematic reviews
por: Raftery, James, et al.
Publicado: (2015)

An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
por: Kanavos, Panos, et al.
Publicado: (2019)

HTA and MCDA solely or combined? The case of priority-setting in Colombia
por: Castro, Héctor E., et al.
Publicado: (2018)

Evaluating facts and facting evaluations: On the fact‐value relationship in HTA
por: Hofmann, Bjørn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_suchv1ub1kket621d5i5oonela